The bacterial pathogen Legionella pneumophila creates an intracellular niche permissive for its replication by extensively modulating host-cell functions using hundreds of effector proteins delivered by its Dot/Icm secretion system 1 . Among these, members of the SidE family (SidEs) regulate several cellular processes through a unique phosphoribosyl ubiquitination mechanism that bypasses the canonical ubiquitination machinery [2] [3] [4] . The activity of SidEs is regulated by another Dot/Icm effector known as SidJ
Letter reSeArCH family effectors from L. pneumophila, which ubiquitinate structurally diverse proteins that are associated with the endoplasmic reticulum 2, 4 . Ubiquitination by SidEs is initiated by means of ADP-ribosylation at R42 of ubiquitin, which is catalysed by mono-ADP ribosyltransferase (mART) 2 . The activated ADP-ribosylated ubiquitin (ADPR-Ub) is then used by a phosphodiesterase-like domain that is also present in SidEs; this domain ligates phosphoribosylated ubiquitin (PR-Ub) to serine residues of substrate proteins 2, 3 . Because both ADPR-Ub and PR-Ub impair the function of eukaryotic cells by inhibiting canonical ubiquitination 3 , which is pivotal for bacterial virulence 10 , it is likely that there exist factors of either bacterial or host origin that function to prevent potential cellular damage caused by these molecules.
The activity of members of the SidE family-such as SdeA-is regulated by SidJ 5 , which is able to suppresses the yeast toxicity of SdeA 6 . SidJ purified from L. pneumophila also seems to remove ubiquitin from modified substrates 7 . Despite these observations, questions about the mechanism of action of SidJ remain. For example, an SdeA mutant with a histidine-to-alanine mutation at residue 277 (SdeA(H277A))-which is defective in phosphodiesterase activity-is still toxic to yeast even though it cannot ubiquitinate substrates 3 . However, whether SidJ can suppress its toxicity is unknown. Furthermore, it is not clear why the deubiquitinase activity is observed only in SidJ purified from L. pneumophila 7 .
We set out to address these questions by constructing a yeast strain that inducibly expressed SdeA(H277A), and found that SidJ effectively suppressed its toxicity (Fig. 1a) . SidJ may therefore neutralize the toxicity of ADPR-Ub or target the ADP-ribosylation activity of SdeA. In addition, SidJ substantially reduced protein modification induced by SdeA and effectively relieved SdeA-induced inhibition of the degradation of hypoxia-inducible factor 1α 3 (Fig. 1b, c) . However, SidJ that was purified from Escherichia coli or from mammalian cells failed to remove ubiquitin from modified proteins, nor did it detectably affect the SdeA-induced ubiquitination of Rab33b (Fig. 1d, e) . Together, these results suggest that SidJ affects the function of SdeA, but its activity in cells cannot be recapitulated by biochemical reactions.
Flag-tagged SdeA (Flag-SdeA) that was coexpressed either with GFP or with the SidJ(D542A/D545A) mutant (carrying asparticacid-to-alanine mutations at residues 542 and 545), which is defective in suppressing SdeA yeast toxicity 6 , was found to robustly modify Rab33b. However, Flag-SdeA obtained from cells coexpressing GFPSidJ (Flag-SdeA*) failed to ubiquitinate Rab33b (Fig. 2a) . We next examined whether SidJ affects the mART activity by carrying out reactions that measure the ability of Flag-SdeA* to use ubiquitin or ADPR-Ub for ubiquitination. Flag-SdeA* lost the ability to catalyse ubiquitination from ubiquitin, but retained the ability to use ADPR-Ub for ubiquitination (Fig. 2b) . Consistently, Flag-mART (SdeA residues SdeA  GFP  GFP-SidJ  GFP-SidJ  (D542A/D545A)   --+  +  +  -+  ----+  ---+ Ub-4×Flag-Rab33b
4×Flag-Rab33b
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Ub-4×Flag-Rab33b Flag-SdeA from HEK293T cells coexpressing relevant proteins was used to ubiquitinate 4×Flag-Rab33b. Ub-Rab33b was detected as described in Fig. 1 . b, Flag-SdeA coexpressed with SidJ retains the ability to ubiquitinate Rab33b with ADPR-Ub. ADPR-Ub or ubiquitin was incubated with Flag-SdeA purified from HEK293T cells coexpressing GFP or GFP-SidJ. NAD + was included in reactions that contained ubiquitin. Rab33b modification was detected with a Flag-specific antibody. c, SidJ inhibits the mART activity of SdeA. 4×Flag-mART (SdeA(563-910)) purified from HEK293T cells coexpressing GFP or GFP-SidJ was incubated with 4×Flag-Rab33b, ubiquitin, NAD + and His 6 -SdeA(E/A) for 2 h at 37 °C before the detection of ubiquitination. d, e, SidJ induces a 129.04-Da post-translational modification on E860 of SdeA. 4×Flag-mART* (d) was subject to analysis by mass spectrometry, which identified a posttranslational modification in the fragment -H 855 GEGTESEFSVYLPEDVALVPVK 877 -(e, left). The tandem mass (MS/MS) spectrum shows the fragmentation profile of the modified peptide -H 855 GEGTE Glu SEFSVYLPEDVALVPVK 877 -, including ions b 5 and b 6 that confirm the modification site at E860 (e, right). HC, heavy chain; LC, light chain. The experiment in each panel was repeated three times with similar results.
Letter reSeArCH 563 to 910, hereafter denoted SdeA(563-910)) 11 that was purified from HEK293T cells expressing GFP-SidJ (Flag-mART*) also failed to ubiquitinate Rab33b with the PDE-competent SdeA(E860A/E862A) mutant 3, 4 (Fig. 2c) . We therefore conclude that SidJ targets the mART activity of SdeA.
Analysis by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) identified a mass shift of 129.04 Da (m/z = 129.04, z = 1) on the peptide -H 855 GEGTESEFSVYLP EDVALVPVK 877 -in Flag-mART* (Fig. 2d, e) . The modificationprobably the addition of a glutamate-was mapped to E860, one of the catalytic residues of the mART 2 ( Fig. 2e) . Approximately 93.7% of E860 was modified in samples coexpressed with GFP-SidJ, and a modification of 258.09 Da (m/z = 258.09, z = 1)-presumably diglutamatewas also detected on a small portion of the same peptide (Extended Data Fig. 1 ). Thus, SidJ may be a glutamylase that ligates one or more glutamate moieties to E860 of SdeA.
We did not detect SidJ activity in reactions containing ATP-the energy source for known glutamylases 12 -and l-glutamate, or its structural isomers N-acetylserine and N-methylaspartate (Extended Data  Fig. 2a) . Because the inhibitory effects of SidJ are evident only when it is expressed in mammalian cells, we tested the hypothesis that its activity requires one or more factors of eukaryotic origin by including lysates of E. coli or HEK293T cells in the reactions. Lysates of HEK293T cells (native or boiled) caused a decrease in Rab33b modification (Extended Data Fig. 2b ), which indicates that one or more heat-stable factors specific to eukaryotic cells are required for the activity of SidJ.
Analysis of the Pfam database 13 of protein families revealed an IQ-like motif, which is involved in CaM binding, located near the carboxyl end of SidJ (Fig. 3a) . The yeast toxicity of SidJ 14 was suppressed by mutations in I841 and Q842-two residues in IQ motifs that are important for CaM binding 15 -or by overexpression of the yeast CaM gene cmd1 (Fig. 3b) , thereby validating the nature of the IQ motif. Indeed, binding between SidJ and CaM occurred in cells that were infected with relevant L. pneumophila strains or that coexpressed these two proteins, and the IQ motif was found to be required for optimal binding (Fig. 3c, d) .
CaM, and SidJ together with l-glutamate-but not the two glutamate isomers-abolished SdeA-mediated ubiquitination (Fig. 3e) . Consistent with the heat-insensitivity seen in mammalian cell lysates, boiled CaM was partially active (Extended Data Fig. 2c) . Notably, we found that SdeA can be modified by 14 C-glutamate only in reactions containing CaM, and that SdeA(E860A) cannot be modified by 14 C-glutamate, establishing that E860 is the major modification site (Fig. 3f) . Similar to other glutamylases 12 , ATP binds SidJ (with a dissociation constant, K d , of 1.45 μM) and is required for SidJ activity (Extended Data Fig. 2d, e) . CaM-dependent inhibition by SidJ was found for all members of the SidE family (Extended Data Fig. 2f ). Under our experimental conditions, 0.006 μM and 0.055 μM of CaM was required to activate SidJ and SidJ(I841D/Q842A) respectively; this explained the observation that SidJ(I841D/Q842A) still complemented the phenotype associated with the ∆sidJ mutant (Extended Data  Fig. 3 ). Together, these results establish that SidJ is a CaM-dependent Letter reSeArCH glutamylase that catalyses the ligation of glutamate moieties to E860 of SdeA.
We further investigated the mechanism of the CaM-dependent glutamylase activity of SidJ by structural analysis. A truncated SidJ that lacks the first 99 residues (SidJ(∆N99)) showed activity that was indistinguishable from that of the full-length protein. Biophysical analysis indicated that it formed a stable heterodimer with CaM at a ratio of 1:1 (Extended Data Fig. 4 ). We solved a structure at 2.71 Å resolution of the SidJ(∆N99)-CaM complex, using a 2.95 Å-resolution structure of the SidJ(Se-Met)-CaM derivative as the search model (Extended Data Table 1 ). In our structure, two SidJ-CaM heterodimeric complexes are found in one asymmetric unit (Extended Data Fig. 5a ). Analysis of the intersubunit contacts in the asymmetric unit suggests that the interface between the two SidJ molecules in the structure results from crystal packing. In the complex, SidJ(∆N99) folds into three distinct domains that we designated as the N-terminal domain, the central domain and the C-terminal domain (Fig. 4a) . CaM docks onto the carboxyl end that contains the IQ motif (Fig. 4b) . The interface area between SidJ and CaM is about 1,574 Å 2 , which accounts for 17.6% of the surface of CaM.
SidJ(∆N99) interacts extensively with CaM through hydrogen bonds and salt bridges. Specifically, Q830 and Q842 of SidJ engage in hydrogen-bonding interactions with E85 and S102 of the CaM C-lobe, respectively. Other hydrogen bonds include S808(SidJ) and E812(SidJ):R38(CaM), R804(SidJ):S39(CaM), R660(SidJ) and R796(SidJ):E15(CaM) (Fig. 4b) . Mutations in these residues reduced the binding affinity of SidJ for CaM (Fig. 4c) .
In order to determine the role of ATP in the activity of SidJ, we crystallized the SidJ(∆N99)-CaM complex in the presence of ATP and obtained a structure at 3.11 Å resolution (Extended Data Table 1 ). We observed an AMP moiety bound in a pocket formed in the central domain. This domain-along with approximately one hundred additional residues-has been designated as the kinase domain in a recent study 16 , in which the same pocket is shown to be occupied by pyrophosphate and Mg 2+ ions. The AMP moiety-which is probably a product of ATP breakdown, induced by SidJ-is coordinated by R352, K367, Y532, N534, R536 and D545 (Fig. 4d) . Substitution of R352, K367, N534, R536 or D545 by alanine abolished the activity of SidJ, whereas a mutation in the distal Y443 had no effect (Fig. 4e) . The binding of AMP does not cause obvious conformational changes in the SidJ(∆N99)-CaM complex (Extended Data Fig. 5b) . In our structures, we observed CaM in a relatively closed conformation 17 with one Ca 2+ coordinated in the EF1 site of CaM (Extended Data Fig. 6a ). However, the B-factor of Ca 2+ was relatively high, indicating partial occupancy of the ion; this is consistent with the partial disorder found in the CaM polypeptide in the crystals. CaM remained active even after dialysis GST-SidJ, l-glutamate and CaM for 2 h at 37 °C before monitoring the activity of SdeA in the ubiquitination of Rab33b. Note that analogues that cannot be hydrolysed at the α site cannot activate SidJ. h, The role of residues important for AMP binding in SidJ self-AMPylation. Each SidJ mutant was incubated with 32 P-α-ATP, Mg 2+ and CaM for 2 h at 37 °C and the incorporation of 32 P-α-ATP was detected by autoradiography. In c, e-h, data shown are one representative from at least three independent experiments with similar results. Data Fig. 6b, c) .
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The presence of AMP in the structure suggests that ATP was cleaved at the α site during the reaction. Indeed, the ATP analogues adenylylimidodiphosphate and ATP-γ-S-which cannot be effectively hydrolysed at the γ site-still activated SidJ (Fig. 4f) . ADP-but not AMP or adenosine-potently induced SidJ activity; in addition, ATP-α-S, which can be slowly hydrolysed at the α site 18 , partially supported SidJ activity. By contrast, ApCpp-which cannot be cleaved at the α-sitefailed to detectably activate SidJ (Fig. 4g) . We therefore conclude that the SidJ-catalysed reaction involves the cleavage of ATP between the α and β phosphates.
Because SidJ-induced cleavage of ATP is analogous to the reaction involved in AMPylation 19 , we thus examined whether SidJ catalyses AMPylation using 32 P-α-ATP. Robust self-AMPylation of SidJ was detected in reactions containing CaM; such modification also occurred in glutamylation reactions that lacked glutamate or modifiable SdeA (Extended Data Fig. 7a, b) . Furthermore, residues that are important for binding AMP are required for self-modification activity (Fig. 4h) . We detected AMP in reactions containing SidJ, CaM and ATP, and the release of AMP was accelerated by SdeA but not by SdeA(E860A) (Extended Data Fig. 7c ). We propose a model in which SidJ activates E860 of SdeA by acyl-adenylation, which is followed by nucleophilic attack of the amino group of free glutamate on the activated carbonyl of the unstable E860-AMP intermediate, leading to glutamylation of E860 and the release of AMP (Extended Data  Fig. 7d) .
Overexpression of SdeA in the ∆sidJ mutant severely affected intracellular bacterial replication 6, 20 , as did expression of SdeA(M408A/ L411A), which is defective in substrate recognition 11 . Such defects were rescued by simultaneous expression of SidJ (Extended Data  Fig. 8 ). We attempted to separate the ubiquitin ligase activity from being the substrate for SidJ by constructing the mutant protein SdeA(E860D). SidJ can neither modify this mutant nor suppress its yeast toxicity. Similarly, its ubiquitin ligase activity is insensitive to SidJ. Of most relevance, the inhibition of intracellular growth of the ∆sidJ strain by SdeA(E860D) cannot be rescued by coexpressing SidJ (Extended Data Fig. 9 ).
The AMP-binding site in our structure is essential for the activation step, but it remains unclear how free glutamate is recognized. The E860-AMP intermediate produced at this site may transit to a second nucleotide-binding site in the same domain for glutamylation 16 . It is also not clear how SidJ selectively targets E860 of SdeA, but not nearby E857 and E862, or whether it modifies other proteins as well as SidEs by glutamylation or AMPylation. The glutamylation of SidEs by SidJ expands the strategies used by L. pneumophila to ensure balanced modulation of host function 1 . SidJ is a unique glutamylase that bears no similarity to mammalian glutamylases 12, 21 . The requirement of CaM for its activity ensures that SidEs will not be inactivated prior to modifying host targets 7 . CaM also activates the oedema factor of Bacillus anthracis and CyaA of Bordetella pertussis 22, 23 , both catalysing the synthesis of the important signalling molecule cyclic AMP 24 . Further study of the mechanism of CaM-induced activation of SidJ and the relationship between the AMPylation and glutamylation reactions is likely to reveal insights into the regulation and function of glutamylases.
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Methods
Media, bacteria strains, plasmid constructions and cell lines. L. pneumophila strains used in this study were derivatives of the Philadelphia 1 strain Lp02 25 and were grown and maintained on CYE plates or in ACES buffered yeast extract (AYE) broth as previously described 25 . The sidJ in-frame deletion strain has been previously described 5 . sidJ and sdeA genes and their mutants were cloned into pZLQ 26 or pZL507 27 for complementation. The E. coli strains XL1-Blue and BL21(DE3) were used for expression and purification of all the recombinant proteins used in this study. E. coli strains were grown in LB medium. Genes for protein purifications were cloned into pQE30 (Qiagen), pGEX-6P-1 (Amersham) and pET-21a (Novagen) for expression. For ectopic expression of proteins in mammalian cells, genes were inserted into the 4×Flag CMV vector 2 or the 3×HAcDNA3.1 vector 28 . HEK293T cells were cultured in Dulbecco's modified minimal Eagle's medium (DMEM) supplemented with 10% FBS. U937 cells were cultured in RPMI 1640 medium supplemented with 10% FBS. The yeast strains BY4741 and W303 were used for toxicity assays. Yeast strains were cultured in YPD media containing yeast extract, peptone and glucose, or SD minimal media containing yeast nitrogen base, glucose and amino acid drop-out mix for selection of transformed plasmids. For GAL1 promoter induction, 2% galactose was used to replace 2% glucose as the sole carbon source in minimal media. To examine the yeast toxicity of SidJ and its mutants, each allele was cloned into pYES1NTA (Invitrogen), which contains GAL1 promoter for inducible expression in yeast 14 . The cmd1 gene was cloned into p415ADH 29 for expression in yeast. For the suppression of the yeast toxicity of SdeA by SidJ, sdeA and its mutants were expressed from pYES1NTA and sidJ was expressed from p425GPD 29 . All mammalian cell lines were regularly checked for potential mycoplasma contamination by the universal mycoplasma detection kit from ATCC (30-1012K). Transfection, infection, immunoprecipitation. Lipofectamine 3000 (Thermo Fisher Scientific) was used to transfect HEK293T cells grown to about 70% confluence. Different plasmids were transfected into HEK293T cells. Transfected cells were collected and lysed with the radioimmunoprecipitation assay buffer (RIPA buffer, Thermo Fisher Scientific) 16-18 h after transfection. Cells infected with indicated bacterial strains were similarly processed for immunoprecipitation. When needed, immunoprecipitation was performed with lysates of transfected cells using agarose beads coated with HA-specific antibody (Sigma-Aldrich, A2095), Flag-specific antibody (Sigma-Aldrich, F1804), or CaM (Sigma-Aldrich, A6112) at 4 °C for 4 h. Beads were washed with pre-cold RIPA buffer or respective reaction buffers three times. Samples were resolved by SDS-PAGE and followed by immunoblotting analysis with the specific antibodies, or silver staining following the manufacturer's protocols (Sigma-Aldrich, PROTSIL1).
For infection experiments, L. pneumophila strains were grown to the postexponential phase (optical density at 600 nm, OD 600 , of 3.3-3.8) in AYE broth. When necessary, complementation strains were induced with 0.2 mM IPTG for 3 h at 37 °C before infection. U937 cells were infected with L. pneumophila strains correspondingly. Cells were collected and lysed with 0.2% saponin on ice for 30 min. Cell lysates were resolved by SDS-PAGE and followed by immunoblotting analysis with the specific antibodies. L. pneumophila bacteria lysates were resolved by SDS-PAGE followed by immunoblotting with the SidJ-and SdeA-specific antibodies to examine the expression of SidJ and SdeA, and isocitrate dehydrogenase (ICDH) was added as a loading control with the antibodies as previously described 27 . For intracellular growth in Acanthamoeba castellanii cells, infection was performed at a multiplicity of infection (MOI) of 0.05 and the total bacterial counts were determined at 24-h intervals as previously described 20 . A. castellanii was maintained in HL5 medium. For infection, HL5 medium was replaced by MB medium with 1 mM IPTG added to overexpress the indicated proteins. Protein purification. Overnight E. coli cultures (10 ml) were transferred to 400 ml LB medium supplemented with 100 μg ml −1 of ampicillin and the cultures were grown to an OD 600 of 0.6-0.8 before induction with 0.2 mM IPTG. Cultures were further incubated at 18 °C overnight. Bacteria were collected by centrifugation at 4,000g for 10 min, and were lysed by sonication in 30 ml PBS. Bacteria lysates were centrifuged twice at 18,000g at 4 °C for 30 min to remove insoluble fractions and unbroken cells. The supernatant containing recombinant proteins was incubated with 1 ml Ni 2+ -NTA beads (Qiagen) or glutathione agarose beads (Pierce) at 4 °C for 2 h with agitation. Ni 2+ -NTA beads with bound proteins were washed with PBS buffer containing 20 mM imidazole three times, using 30 times the column volume each time. Proteins were eluted with PBS containing 300 mM imidazole. Glutathione agarose beads were washed with a Tris buffer (50 mM Tris-HCl (pH 8.0)) and eluted with 10 mM reduced glutathione in the same buffer. Proteins were dialysed in buffer containing 25 mM Tris-HCl (pH 7.5), 150 mM NaCl and 1 mM dithiothreitol (DTT) for 16-18 h. The native SidJ(∆N99) was purified using the same protocol, and the protocol used to purify CaM was similar to this but with the addition of 2 mM CaCl 2 and 10% glycol. For crystallization, the SidJ-CaM complex was formed by mixing these two proteins in 20 mM Tris-HCl (pH 8.0), 150 mM NaCl and 2 mM CaCl 2 .
For protein purification from mammalian cells, HEK293T cells were transfected with corresponding plasmids to express Flag-tagged proteins. Cells were lysed with RIPA buffer, and subject to immunoprecipitation with beads coated in Flag-specific antibody. Proteins were then eluted from the beads by using 3×Flag peptides following the manufacturer's protocol (Sigma-Aldrich, F4799). Crystallization. The purity of SidJ(∆N99)-CaM was around 95% as assessed by SDS-PAGE, and initial crystallization screens of native SidJ-CaM were conducted by sitting-drop vapour diffusion using commercial crystallization screens. The protein concentration used for crystallization was 5-7 mg ml . Diffraction quality crystals of SidJ(Se-Met)-CaM were grown and optimized under the same conditions. All crystals were flash-frozen in liquid nitrogen, with the addition of 20-25% (v/v) glycerol as a cryoprotectant. Data collection and structure determination. X-ray diffraction for SidJ(∆N99/SeMet)-CaM, native SidJ(∆N99)-CaM and SidJ(∆N99)-CaM-ATP were collected at beamline BL-17U1 of the Shanghai Synchrotron Radiation Facility. All data were indexed and scaled using HKL2000 software 30 . The initial phase of SidJ(∆N99)-CaM was determined by using the single-wavelength anomalous dispersion phasing method. Phases were calculated using AutoSol implemented in PHENIX 31 . AutoBuild in PHENIX was used to automatically build the atom model. Molecular replacement was then performed with this model as a template to determine the structure of other complexes. After several rounds of positional and B-factor refinement using phenix.refine with TLS parameters alternated with manual model revision using Coot 32 , the quality of final models was checked using the PROCHECK program (https://www.ebi.ac.uk/thornton-srv/software/PROCHECK). The quality of the final model was validated with MolProbity 33 . Structures were analysed with PDBePISA (Protein Interfaces, Surfaces, and Assemblies) 34 , Dali (http://ekhidna2. biocenter.helsinki.fi/dali), and details of the data collection and refinement statistics are given in Extended Data Table 1 . All of the figures showing structures were prepared with PyMOL (http://www.pymol.org). In the final models, the model for the SidJ(∆N99/Se-Met)-CaM complex contained 91.05%, 8.58% and 0.16% in the favoured, allowed and outlier regions of the Ramachandran plot, respectively. The model for the SidJ(∆N99)-CaM complex contained 93.25%, 6.63% and 0.10% in the favoured, allowed and outlier regions of the Ramachandran plot, respectively. The final model for the SidJ(∆N99)-CaM-AMP complex contained 92.10%, 7.76% and 0.00% in the favoured, allowed and outliers regions of the Ramachandran plot, respectively. Analytic ultracentrifugation. Sedimentation velocity experiments were used to assess the molecular size of the SidJ(∆N99)-CaM complex at 20 °C on a Beckman XL-A analytical ultracentrifuge equipped with absorbance optics and an An60 Ti rotor (Beckman Coulter). Samples were diluted to an optical density at 280 nm (OD 280 ) of 1 in a 1.2-cm path length. The rotor speed was set to 72,500g for all samples. The sedimentation coefficient was obtained using the c(s) method with the Sedfit software. In vitro ubiquitination assays. For the SdeA-mediated ubiquitination reaction, 0.1 μg His 6 -SdeA and 1 μg GST-SidJ were preincubated in a 25-μl reaction system containing 50 mM Tris-HCl (pH 7.5), 1 mM DTT and 1 mM β-NAD + for 2 h at 37 °C. When needed, 5 mM MgCl 2 , 1 mM l-glutamate, 1 mM ATP and 1 μM CaM (Sigma-Aldrich, C4874) were supplemented. After a 2-h preincubation, a cocktail containing 1 mM β-NAD + , 0.25 μg 4×Flag-Rab33b and 5 μg ubiquitin was supplemented into the reactions and the reaction was allowed to proceed for another 2 h at 37 °C. In vitro glutamylation assays. His 6 -SdeA (0.1 μg) and GST-SidJ (1 μg) were incubated in a 25-μl reaction system containing 50 mM Tris-HCl (pH 7.5), 1 mM DTT, 5 mM MgCl 2 , 1 mM l-glutamate, 1 mM ATP and 1 μM CaM for 2 h at 37 °C. To measure the glutamylase activity of SidJ using 14 C-glutamate, 2 μg His 6 -SdeA and 0.5 μg GST-SidJ were incubated in a 25-μl reaction system containing 50 mM Tris-HCl (pH 7.5), 1 mM DTT, 5 mM MgCl 2, 1 μCi 14 C-l-glutamate (Perkin Elmer NEC290E050UC), 1 mM ATP and 1 μM CaM for 2 h at 37 °C. Products were resolved by SDS-PAGE and stained with Coomassie Brilliant Blue. Gels were then dried and signals were detected with X-ray films with a BioMax TranScreen LE (Kodak) for 3 days at −80 °C. In vitro AMPylation assays. GST-SidJ (2 μg) was incubated in a 25-μl reaction system containing 50 mM Tris-HCl (pH 7.5), 1 μM CaM, 1 mM DTT, 5 mM MgCl 2 and 5 μCi ATP-α-32 P (Perkin Elmer BLU003H250UC) for 2 h at 37 °C. When needed, 3 μg His 6 -SdeA and 1 mM l-glutamate were supplemented. Products were Letter reSeArCH resolved by SDS-PAGE and stained with Coomassie Brilliant Blue. Gels were then dried and signals were detected with X-ray films. HPLC analysis of glutamylation reactions. SidJ(∆N99) (40 μg) was incubated with 1 mM ATP in a 100-μl reaction system containing 50 mM Tris-HCl (pH 7.5) and 50 mM NaCl for 4 h at 37 °C. When needed, 1 mM CaM, 2 mM l-glutamate and 80 μg SdeA or SdeA(E860A) were supplemented. Samples were injected into a Waters Acquity UPLC system equipped with a C18 reversed-phase column and a UV detector. Components were eluted isocratically with 100% H 2 O for 2 min followed by a 10-min gradient to 95% H 2 O and 5% acetonitrile. ATP and AMP (1 mM) were run as standards. Antibodies and immunoblotting. Purified His 6 -GFP was used to raise rabbitspecific antibodies using a standard protocol (Pocono Rabbit Farm and Laboratory). The antibodies were affinity-purified as previously described 20 . Antibodies specific for SidJ and SdeA have been previously described 2, 5 ; commercial antibodies used are as follows: anti-Flag (Sigma-Aldrich, F1804; 1:2,000); anti-HA (Roche, 11867423001; 1:5,000), anti-ICDH 27 (1:10,000); anti-tubulin (DSHB, E7; 1:10,000); anti-HIF-1α (R&D Systems, MAB1536; 1:1,000); anti-PGK1 (Abcam, ab113687; 1:2,500); anti-CaM (Millipore, 05-173; 1:2,000). Membranes were then incubated with an appropriate IRDye infrared secondary antibody and scanned using an Odyssey infrared imaging system (Li-Cor's Biosciences). Constitution of the SidJ-CaM complex and size-exclusion chromatography. Proteins purified as described above were further purified using a size-exclusion chromatography column (Superdex 200 increase 10/300; GE Healthcare) equilibrated with a washing buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl) on an AKTA pure system (GE Healthcare). To constitute the protein complex, purified SidJ and CaM were mixed at a 1:1.2 molar ratio at 4 °C for 1 h on a rotary shaker, and the complex was purified by size-exclusion chromatography using the above column. In each case, the proteins were eluted with the washing buffer. Fractions containing the protein of interest were pooled and used for further analysis. Liquid chromatography-tandem mass spectrometry analysis. The Flag-mART domain was purified from HEK293T cells coexpressing GFP-SidJ or GFP. After separation by SDS-PAGE, gel slices containing the protein detected by silver staining were digested as described previously 35 . The digested peptides were analysed on a C18 reversed-phase column connected to a UPLC (Acquity, Waters) coupled to an Orbitrap mass spectrometer (Q-Exactive Plus, Thermo Fisher Scientific), using the same conditions as described previously 36 . Tandem mass spectra were converted to peak lists using DeconMSn 37 and submitted for blind posttranslational modification search using MODa 38 against the L. pneumophila sequences from GenBank. Post-translational-modification candidates were confirmed by manual inspection, looking for consistent mass shifts in b and y fragment series, and by reprocessing the data with MaxQuant 39 considering the specific modifications. Microscale thermophoresis. The interaction between SidJ and CaM and the ATP-binding activity of SidJ were measured by microscale thermophoresis using the NanoTemper Monolith NT.115 instrument set at 20% LED and 20-40% IR-laser power. Laser on and off times were set at 30 s and 5 s, respectively. Each measurement consists of 16 reaction mixtures in which the concentration of fluorescent-labelled SidJ was set to be constant at 150 nM and the concentration of two fold-diluted CaM ranged from 20 μM to 0.61 nM. For ATP binding, the concentrations of ATP used were from 100 μM to 3.05 nM. The NanoTemper Analysis 2.2.4 software was used to fit the data and to determine the K d . Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
The atomic coordinates and structure factors of the SidJ(Se-Met)-CaM, SidJ-CaM and SidJ-CaM-AMP have been deposited in the Protein Data Bank (PDB) under the accession codes 6K4L, 6K4K and 6K4R, respectively. Fig. 2 | The effects of cell lysates, ATP and heat treatment of CaM on the activity of SidJ and its inhibition of the activity of all members of the SidE family. a, Inhibition of SdeA activity does not occur in in vitro reactions containing l-glutamate or each of its two structural isomers. l-glutamate, N-acetylserine or N-methylaspartate was incubated with SdeA, SidJ and ATP for 2 h before assaying for the activity of SdeA. b, One or more factors from mammalian cells are required for SidJ to inhibit SdeA. Lysates from E. coli or HEK293T cells were added to reactions containing SdeA and SidJ for 2 h before measuring the activity of SdeA. c, Heat treatment does not completely abolish CaM activity. CaM or CaM treated by heating at 100 °C for 5 min was included in reactions that allow glutamylation of SdeA for 2 h. A cocktail containing 4×Flag-Rab33b, NAD + and ubiquitin was added to each reaction. Samples were resolved by SDS-PAGE and analysed for Rab33b ubiquitination after another 2 h incubation at 37 °C. d, The activity of SidJ requires ATP. His 6 -SdeA was incubated with GST-SidJ, l-glutamate and CaM in reactions with or without 1 mM ATP for 2 h; 4×Flag-Rab33b,
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+ and ubiquitin were added to each reaction. After another 2-h incubation, the activity of SdeA was evaluated by the production of ubiquitinated Ra33b. Protein components in the reactions were detected by immunoblotting with specific antibodies. e, The binding of ATP by SidJ. Binding of ATP by purified SidJ was evaluated using microscale thermophoresis in which the concentration of SidJ was kept constant. K d was determined by the NanoTemper Analysis 2.2.4 software. f, SidJ inhibits the activity of members of the SidE family. A recombinant protein of each member of the SidE family was incubated with ATP, l-glutamate and GST-SidJ in the presence or absence of CaM for 2 h, and a cocktail containing 4×Flag-Rab33b, NAD + and ubiquitin was added to the reactions. After an additional 2-h incubation, modification of Rab33b was detected by immunoblotting with a Flag-specific antibody. The formation of Ub-4×Flag-Rab33b is indicated by a shift in molecular mass. In each panel, data shown are one representative from at least three independent experiments with similar results. The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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